Borosil released scientific division results yesterday and it continue to face headwinds as management mentioned in the last concall. Revenue grown 6% and EBITDA/PAT grown at around 15% yoy. Its been couple of months already since the spin off but the shares are still not listed in the exchanges. This will be a point of discussion in the coming concall.
Q3 FY24 | Q3 FY23 | YOY | Q2 FY24 | QOQ | 9M FY24 | 9M FY23 | YOY | |
---|---|---|---|---|---|---|---|---|
Revenue | 88.42 | 83.32 | 6.12% | 84.35 | 4.83% | 252.48 | 235.03 | 7.42% |
EBITDA | 14.75 | 12.9 | 14.34% | 13.85 | 6.50% | 35.91 | 35.41 | 1.41% |
EBITDA % | 16.68% | 15.48% | 7.75% | 16.42% | 1.60% | 14.22% | 15.07% | -5.60% |
PAT | 7.45 | 6.45 | 15.50% | 7.74 | -3.75% | 19.39 | 18.92 | 2.48% |
PAT % | 8.43% | 7.74% | 8.84% | 9.18% | -8.18% | 7.68% | 8.05% | -4.60% |
Subscribe To Our Free Newsletter |